Skip to main content

Part of the book series: Methods in Clinical Pharmacology ((MECLPH,volume 3))

  • 57 Accesses

Summary

Bioavailability problems of methylxanthines Information on the pharmacokinetics of theophylline is essential for the design of meaningful bioavailability studies. Theophylline disposition is affected interindividually by various factors (genetics, environment, disease states), but intraindividual variation in bioavailability is also substantial. Parameters for evaluation of bioavailability are the area under the plasma level time curve, maximum plasma concentration and time of its occurrence, and renal elimination. Absorption of theophylline is influenced by route and form of application, by gastrointestinal diseases and by drug interactions. Methodological problems in bioavailability studies with theophylline concern analysis of the drug, study design, and evaluation of results. Literature data usually show good bioavailability of theophylline.

Zusammenfassung

Eine Voraussetzung für die sinnvolle Planung von Bioverfügbarkeitsstudien mit Theophyllin ist die Kenntnis der pharmakokinetischen Eigenschaften. Die Disposition von Theophyllin wird interindividuell durch zahlreiche Faktoren beeinflußt (Genetik, Umwelt, Erkrankungen), doch ist auch die intraindividuelle Variation der Bioverfügbarkeit groß. Bioverfügbarkeitsparameter sind die Fläche unter der Plasmaspiegelkurve, Zeitpunkt und Höhe der maximalen Plasmakonzentration und renale Ausscheidung. Die Resorption wird durch Applikationsort, Applikationsform, gastrointestinale Erkrankungen und durch Interaktionen beeinflußt. Methodische Probleme der Bioverfügbarkeit von Theophyllin betreffen Analytik, Studienplanung und. Auswertung der Ergebnisse. Die in der Literatur mitgeteilten Daten zeigen in der Regel eine gute Bioverfügbarkeit von Theophyllin.

Mit Unterstützung durch die Gesellschaft für Strahlen und Umweltforschung mbH, München

Stipendiat der Alexander-von-Humboldt-Stiftung

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bolme, P., Edlund, P. O., Eriksson, M., Paalzow, L., Windbladh, B.: Pharmacokinetics of theophylline in young children with asthma: Comparison of rectal enema and suppositories. Europ. J. Clin. Pharmacol. 16, 133–139 (1979).

    Google Scholar 

  2. Charles, B. B., Med. J. Austral. 2, 264 (1980).

    PubMed  CAS  Google Scholar 

  3. Grygiel, J. J., Wing, L. M. H., Farkas, J., Birkett, D. J.: Effects of allopurinol on theophylline metabolism and clearance. Clin. Pharmacol. Ther. 26, 660–667 (1979).

    PubMed  CAS  Google Scholar 

  4. Jonkman, J. H. G.: Disposition and clinical pharmacokinetics of microcrystalline theophylline. Europ. J.Clin.Pharmacol. 17, 379–384 (1980).

    Article  CAS  Google Scholar 

  5. Lamont, H., Moerman, E., Bogaert, M., van der Straeten, M., Pauwels, R.: Plasma theophylline level and effect on lung function after oral and rectal administration of aminophylline. Europ. J. Clin. Pharmacol. 15, 401–406 (1979).

    Article  CAS  Google Scholar 

  6. Mason, W. D., Langman, R. C., Amick, N. E., Arnold, J., March, L.: Bioavailability ot theophylline following rectally administered concentrated aminophylline solution. J. Allergy Clin. Immunol. 66, 119–122 (1980).

    Article  PubMed  CAS  Google Scholar 

  7. Ogilvie, R. J.: Clinical pharmacokinetics of theophylline. Clin. Pharmacokin. 3, 267–293 (1978).

    Article  CAS  Google Scholar 

  8. Somogyi, A., Gugler, R.: Absolute Bioverfügbarkeit von Theophyllin. Fortschr. Med. 98, 1707– 1710 (1980).

    PubMed  CAS  Google Scholar 

  9. Trembath, P. W., and Boobis, S. W.: Plasma theophylline levels after sustained release aminophylline. Clin. Pharmacol. Ther. 26, 654–659 (1979).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Friedr. Vieweg & Sohn Verlagsgesellschaft mbH, Braunschweig

About this chapter

Cite this chapter

Gugler, R., Somogyi, A. (1982). Probleme der Bioverfügbarkeit von Methylxanthinen. In: Rietbrock, N., Woodcock, B.G., Staib, A.H. (eds) Theophylline and other Methylxanthines / Theophyllin und andere Methylxanthine. Methods in Clinical Pharmacology, vol 3. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-663-05268-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-663-05268-5_3

  • Publisher Name: Vieweg+Teubner Verlag, Wiesbaden

  • Print ISBN: 978-3-663-05269-2

  • Online ISBN: 978-3-663-05268-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics